trihexyphenidyl has been researched along with Bewilderment in 3 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Robinson, ML | 1 |
McEvoy, JP | 1 |
McCue, M | 1 |
Spring, B | 1 |
Mohs, RC | 1 |
Lavori, PW | 1 |
Farr, RM | 1 |
Martin, WE | 1 |
Loewenson, RB | 1 |
Resch, JA | 1 |
Baker, AB | 1 |
2 trials available for trihexyphenidyl and Bewilderment
Article | Year |
---|---|
Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
Topics: Age Factors; Aged; Amantadine; Confusion; Dose-Response Relationship, Drug; Double-Blind Method; Fem | 1987 |
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therap | 1974 |
1 other study available for trihexyphenidyl and Bewilderment
Article | Year |
---|---|
Drug side effects and the double-blind design.
Topics: Amantadine; Confusion; Double-Blind Method; Humans; Memory Disorders; Research Design; Trihexyphenid | 1988 |